Stocks
GlaxoSmithKline (GSK) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 18.3 | 9.52 | 17.6 | 17.6 | 17.6 | 16.0 | ||
| Changes by years, y/y, % | +49% | -48% | +84% | 0% | +0% | +5.8% | |||
GlaxoSmithKline. EV/EBITDA
GlaxoSmithKline. EV/EBITDA, changes, %
GlaxoSmithKline (GSK) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | 16.9 | 16.4 | 16.3 | 16.1 | 18.9 | 16.0 | |
| Changes by years, y/y, % | +34% | +129% | -2% | -3% | +2% | |||
| Changes by quarters, q/q, % | +51% | -3% | -1% | -1% | +18% | |||
